The problems of drug treatment of breast cancer.
D000367:Age Factors; D000477:Alkylating Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000150:complications; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000628:therapy; D003345:Corticosterone / Q000627:therapeutic use; D004338:Drug Combinations; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D005500:Follow-Up Studies; D006728:Hormones / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010996:Pleural Effusion; D010997:Pleural Neoplasms / Q000150:complications / Q000188:drug therapy; D011372:Progestins / Q000627:therapeutic use; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000728:Androgens; D004338:Drug Combinations; D004967:Estrogens; D006728:Hormones; D011372:Progestins; D014750:Vincristine; D014747:Vinblastine; D005472:Fluorouracil; D003345:Corticosterone; D008727:Methotrexate